Antibody Engineering & Therapeutics US is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Eben Rosenthal
Ann & John Doerr Director of Cancer Services at Stanford University

Profile

Dr. Eben Rosenthal serves as the Ann and John Doerr Medical Director of the Stanford Cancer Center. He oversees the clinical delivery of cancer care across Stanford Medicine and Regional Networks. He has conducts early phase clinical trials using antibodies to develop diagnostic and therapeutic strategies to manage solid tumors. He leads a multidisciplinary team of surgeons, medical oncologists, and radiologists to perform clinical and basic studies that have conducted human clinical trials using fluorescently labeled antibodies to identify the radiologic and biomarkers that predicts homogenous delivery of the antibody to the tumor. He has over 200 publications and has been continuously funded by the NIH for almost 2 decades. He is clinically active in head and neck cancer surgery and microvascular reconstruction.

Eben Rosenthal's Network

Agenda Sessions

  • Assessment of Delivery and Cellular Distribution of Therapeutic Antibodies in Early Phase Clinical Trials by Fluorescent Labeling

    ,